BCL2 and breast carcinoma: When added to Hs578 T breast cancer cells, amygdalin (10–40 mg mL−1) drastically reduced Bcl-2 expression while increasing Bax expression and triggering the cleavage of caspase-3 and poly ADP-ribose polymerase [93].